Zobrazeno 1 - 10
of 3 181
pro vyhledávání: '"chemotherapy‐induced nausea and vomiting"'
Publikováno v:
中西医结合护理, Vol 10, Iss 9, Pp 28-34 (2024)
Objective To establish a non-vomiting management model of laminar flow ward for patients undergoing hematopoietic stem cell transplantation and analyze its clinical application effect, so as to reduce the incidence of nausea and vomiting and improve
Externí odkaz:
https://doaj.org/article/6341a395c76e42c4ac5bba6d5fe12804
Autor:
M. B. Pak, P. A. Zeynalova, A. M. Mudunov, S. V. Berelavichus, F. U. Tankieva, I. A. Duguzheva
Publikováno v:
Опухоли головы и шеи, Vol 14, Iss 2, Pp 27-35 (2024)
Despite the widespread use of immuno-oncological and targeted therapy in the treatment of malignant tumors, in real clinical practice the role of chemotherapy is still significant, used both in mono regimen and in combination with other antitumor dru
Externí odkaz:
https://doaj.org/article/1ae791794bda4095a73a895dd359c275
Autor:
Cong Wang, Zhansheng Jiang, Jie Zhang, Yan Zhuang, Lining Sun, Jing Zhang, Manman Quan, Lan Lan, Yanwei Li, Bin Wang, Zhanyu Pan, Zhuchen Yan
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Objective To evaluate the safety and efficacy of the granisetron transdermal delivery system (GTDS) combined with Dexamethasone for preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving Capecitabine plus Oxaliplati
Externí odkaz:
https://doaj.org/article/1d388c87834145dcaf7c74349ee039cb
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin’s lymphoma, for which cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab(R–CHOP) is one of the standard regimens. Given that R–CHOP is
Externí odkaz:
https://doaj.org/article/bc94cd0b8d004c028e515c1d25aa9cda
Autor:
Chunhui Ning, Yunzi Yan, Yansong Wang, Rui Li, Wenjie Liu, Linjie Qiu, Lingyun Sun, Yufei Yang
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundCINV is a frequent adverse response to cancer treatment. There is still much to learn about the pathophysiology and initiating event of CINV, which necessitates continued research despite decades of effort. Identifying the current foci of t
Externí odkaz:
https://doaj.org/article/8a8d9c21eadd4e678f29beb125faac9d
Publikováno v:
中西医结合护理, Vol 10, Iss 1, Pp 120-124 (2024)
Nausea and vomiting is one of the common adverse drug reactions associated with chemotherapy in cancer patients, and it has negative impact on following treatment and health-related quality of life. Traditional Chinese Medicine (TCM) external treatme
Externí odkaz:
https://doaj.org/article/e13b3c9d25174be787231a5642c22057
Publikováno v:
Oral Oncology Reports, Vol 10, Iss , Pp 100497- (2024)
Chemotherapy-Induced Nausea and Vomiting (CINV) treatment prevails as a principal clinical problem in modern oncology, leading to poor quality of life of patients and a threat for compliance with treatment regimens. Electronic patient-reported outcom
Externí odkaz:
https://doaj.org/article/2c9aa891a88849149dbf5ef93608c455
Publikováno v:
Heliyon, Vol 10, Iss 10, Pp e30965- (2024)
Background: Chemotherapy-induced nausea and vomiting (CINV) is the most common adverse effect of chemotherapy and affects the continuation of chemotherapy in cancer patients. Electrical acupoint stimulation (EAS), which includes electroacupuncture an
Externí odkaz:
https://doaj.org/article/e2891ec5f2c947afa9da28324d2c77e5
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundPatients undergoing chemotherapy often encounter troubling and common side effects, notably Chemotherapy-induced nausea and vomiting (CINV). This side effect not only impairs the patient’s quality of life but could also result in the inte
Externí odkaz:
https://doaj.org/article/cd16df0aab4e4fbdbce33d42c89451a5
Publikováno v:
Zhongguo aizheng zazhi, Vol 33, Iss 11, Pp 1009-1017 (2023)
Background and purpose: Chemotherapy-induced nausea and vomiting (CINV) can cause severe damage to body functions and even lead to death. The prevention of CINV is critically important in patients receiving emetogenic chemotherapy regimen. This study
Externí odkaz:
https://doaj.org/article/05e6bfe4173f47fb8f8222622718e33e